Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.04
0.080.62%
At close: -
$13.04
0.000.00%
After Hours: Jun 20, 4:00 PM EDT
Comments
Loading...
Ardent Health Analyst Ratings and Price Targets | NYSE:ARDT | Benzinga
Ardent Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Ardent Health Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stephens & Co.
RBC Capital
Guggenheim
Mizuho
Stephens & Co.
1calculated from analyst ratings
Analyst Ratings for Ardent Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/20/2025 | Buy Now | — | Stephens & Co. | Scott Fidel 41% | $21 → $21 | Reiterates | Overweight → Overweight | Get Alert |
| 05/15/2025 | Buy Now | — | RBC Capital | Ben Hendrix59% | $21 → $21 | Reiterates | Outperform → Outperform | Get Alert |
| 05/09/2025 | Buy Now | — | Guggenheim | Jason Cassorla47% | $16 → $18 | Maintains | Buy | Get Alert |
| 04/09/2025 | Buy Now | — | Guggenheim | Jason Cassorla47% | → $16 | Initiates | → Buy | Get Alert |
| 04/09/2025 | Buy Now | — | Mizuho | Ann Hynes86% | $19 → $18 | Maintains | Outperform | Get Alert |
| 04/01/2025 | Buy Now | — | Stephens & Co. | Scott Fidel 41% | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
| 03/26/2025 | Buy Now | — | Stephens & Co. | Scott Fidel 41% | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
| 03/04/2025 | Buy Now | — | RBC Capital | Ben Hendrix59% | $23 → $21 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | — | Stephens & Co. | Raj Kumar 54% | $22 → $22 | Reiterates | Overweight → Overweight | Get Alert |
| 01/21/2025 | Buy Now | — | Morgan Stanley | Craig Hettenbach58% | $23.5 → $22 | Maintains | Overweight | Get Alert |
| 01/06/2025 | Buy Now | — | Truist Securities | David Macdonald65% | $22 → $21 | Maintains | Buy | Get Alert |
| 12/17/2024 | Buy Now | — | JP Morgan | Benjamin Rossi66% | → $20 | Assumes | → Neutral | Get Alert |
| 11/14/2024 | Buy Now | — | RBC Capital | Ben Hendrix59% | $23 → $23 | Reiterates | Outperform → Outperform | Get Alert |
| 11/12/2024 | Buy Now | — | Leerink Partners | Whit Mayo66% | $23 → $25 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | $22 → $19 | Downgrade | Buy → Neutral | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor65% | → $24 | Initiates | → Overweight | Get Alert |
| 09/19/2024 | Buy Now | — | Stephens & Co. | Scott Fidel68% | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 08/16/2024 | Buy Now | — | Truist Securities | David Macdonald65% | $21 → $22 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2024 | Buy Now | — | Loop Capital | Timothy Greaves50% | $18 → $21 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | — | Stephens & Co. | Scott Fidel68% | $24 → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 08/12/2024 | Buy Now | — | B of A Securities | Kevin Fischbeck67% | → $22 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | RBC Capital | Ben Hendrix59% | → $23 | Initiates | → Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | Citigroup | — | → $21 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Loop Capital | Timothy Greaves50% | → $18 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Leerink Partners | Whit Mayo66% | → $23 | Initiates | → Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | JP Morgan | Lisa Gill56% | → $18 | Initiates | → Neutral | Get Alert |
| 08/12/2024 | Buy Now | — | Truist Securities | David Macdonald65% | → $21 | Initiates | → Buy | Get Alert |
| 08/12/2024 | Buy Now | — | Mizuho | Ann Hynes86% | → $20 | Initiates | → Outperform | Get Alert |
| 08/12/2024 | Buy Now | — | Morgan Stanley | Craig Hettenbach58% | → $27 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Ardent Health (ARDT) stock?
The latest price target for Ardent Health (NYSE:ARDT) was reported by Stephens & Co. on May 20, 2025. The analyst firm set a price target for $21.00 expecting ARDT to rise to within 12 months (a possible 61.04% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ardent Health (ARDT)?
The latest analyst rating for Ardent Health (NYSE:ARDT) was provided by Stephens & Co., and Ardent Health reiterated their overweight rating.
When was the last upgrade for Ardent Health (ARDT)?
There is no last upgrade for Ardent Health
When was the last downgrade for Ardent Health (ARDT)?
The last downgrade for Ardent Health Inc happened on November 6, 2024 when B of A Securities changed their price target from $22 to $19 for Ardent Health Inc.
When is the next analyst rating going to be posted or updated for Ardent Health (ARDT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ardent Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ardent Health was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.
Is the Analyst Rating Ardent Health (ARDT) correct?
While ratings are subjective and will change, the latest Ardent Health (ARDT) rating was a reiterated with a price target of $21.00 to $21.00. The current price Ardent Health (ARDT) is trading at is $13.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
